Douglas Losordo, EVP, Global Head of Research and Development and C at Lisata Therapeutics, holds 5.00K shares in Longeveron (Ticker: LGVN), holds 130.41K shares in Lisata Therapeutics (Ticker: LSTA), holds ― shares in Cadrenal Therapeutics, Inc. (Ticker: CVKD).